Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
August 27, 2019
Patent Application Number
15896378
Date Filed
February 14, 2018
Patent Citations
Patent Primary Examiner
Patent abstract
The invention provides pyrazolyl guanidine compounds that inhibit F1F0-ATPase, and methods of using pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
